TY  - GEN
AU  - Carbonell, Caterina
AU  - Frigola, Joan
AU  - Pardo, Nuria
AU  - Callejo, Ana
AU  - Iranzo, Patricia
AU  - Valdivia, Augusto
AU  - Priano, Ilaria
AU  - Cedrés, Susana
AU  - Martinez-Marti, Alex
AU  - Navarro, Alejandro
AU  - Lenza, Laura
AU  - Soleda, Mireia
AU  - Gonzalo-Ruiz, Javier
AU  - Vivancos, Ana
AU  - Sansó, Miriam
AU  - Carcereny, Enric
AU  - Morán, Teresa
AU  - Amat, Ramon
AU  - Felip, Enriqueta
PY  - 2023
DO  - 10.1002/1878-0261.13409
UR  - https://hdl.handle.net/20.500.12105/23640
AB  - Immune checkpoint inhibitors (ICIs) targeting the PD-1/PD-L1 axis are the main therapeutic option for patients with advanced non-small cell lung cancer (NSCLC) without a druggable oncogenic alteration. Nevertheless, only a portion of patients benefit...
LA  - eng
PB  - Wiley
KW  - Lung Neoplasms
KW  - Biomarkers, Tumor
KW  - B7-H1 Antigen
KW  - Treatment Outcome
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Humans
KW  - Cell-Free Nucleic Acids
KW  - Circulating Tumor DNA
TI  - Dynamic changes in circulating tumor DNA assessed by shallow whole-genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC
TY  - research article
ER  -